GlaxoSmithKline‘s (NYSE:GSK) HIV treatment combivir will soon face its first competition from a generic drug. Teva Pharmaceutical Industries (NASDAQ:TEVA) has received U.S. Food and Drug Administration approval on its application to market a generic version of combivir. Combivir is a combination drug that pairs azidothymidine, also known as AZT, with another antiviral, lamivudine. The combination […]
Drug delivery company CIMA Labs in Brooklyn Park, Minnesota, will come under Israeli firm Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) as part of Teva’s acquisition of CIMA parent company Cephalon Inc. (NASDAQ:CEPH), a pharmaceutical company which is based in Frazer, Pennsylvania. Teva and Cephalon announced today that Teva will pay $81.50 per share of each outstanding […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.